Mark E. Schneiderhan, PharmD, BCPP

  • 3Articles
  • 15.4KReads
  • 2014–2023Active
  • 10Collaborators
  • 44Citations

About

Mark E. Schneiderhan, PharmD, BCPP is affiliated with University of Minnesota College of Pharmacy, Department of Pharmacy Practice and Pharmaceutical Sciences, Duluth, Minnesota; Human Development Center, Department of Psychiatry, Duluth, Minnesota; Mark E. Schneiderhan, PharmD, BCPP, University of Minnesota—Duluth, Department of Pharmacy Practice and Pharmaceutical Sciences, 232 Life Science 1110 Kirby Drive, Duluth, Minnesota 55812-3003 ([email protected]). Mark E. Schneiderhan has authored or co-authored 3 peer-reviewed articles published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders between 2014 and 2023. Their work focuses on Patient Care.

Publications

PCC
Initiative to Improve Antipsychotic Metabolic Monitoring
Original Research

Initiative to Improve Antipsychotic Metabolic Monitoring

June 27, 2023

Interprofessional monthly care conferences can improve coordination of care across mental health and primary care settings.
, , , et al
PCC
Original Research

Observed Sex Differences in Cardiometabolic Indices in Patients on Antipsychotics

April 8, 2021

Recognition of sex differences can promote a more personalized patient-centered care approach to ensure goals of therapy are achieved among patients prescribed antipsychotics. Read on to find out more.
,
PCC
Article

Twelve-Month Prospective Randomized Study of Pharmacists Utilizing Point-Of-Care Testing for Metabolic Syndrome and Related Conditions in Subjects Prescribed Antipsychotics

October 15, 2014

To address the gaps in metabolic monitoring, a prospective study of 120 subjects was conducted in three community mental health settings to primarily see if point-of-care testing of lipids,...
, ,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe